Vitamin B12 deficiency is usually associated with fatigue, anaemia, and tingling in the hands and feet. Its psychiatric presentations receive far less attention in general practice, despite case literature showing they can be incredibly dramatic.
B12 absorption is not always straightforward. Vitamin B12 must first be released from dietary protein by stomach acid before it can be bound to intrinsic factor and absorbed further along the digestive tract. When stomach acid is low, whether from chronic stress, age-related decline, acid-suppressing medication or other causes, B12 liberation from food is impaired. Over time, this reduced absorption can contribute to both neurological and psychiatric symptoms.
B12 is required for methylation reactions throughout the body and it supports the integrity of myelin which is the insulating sheath around nerve fibres. It is involved in the synthesis of monoamine neurotransmitters and it regulates homocysteine, an amino acid that becomes neurotoxic when it accumulates in excess. When B12 is low, all of these functions are affected simultaneously, which helps explain why its deficiency can present with such a wide range of neuropsychiatric symptoms.
B12 deficiency has been linked in the literature to depression, cognitive impairment, brain fog, paranoia and psychosis. Several case reports illustrate how severe and reversible, these presentations can be.
One case describes an adult male presenting with acute persecutory delusions and significant behavioural disturbance, with no clear organic cause identified on initial assessment. His B12 level was found to be below 9 pg/mL, profoundly deficient against a reference range typically between 200 and 950. Following B12 replacement therapy, his psychiatric symptoms improved significantly.
Another case involved a sixteen-year-old presenting with irritability, apathy, and mood disturbance with psychotic features. Investigation revealed a B12 level of approximately 150 to 200 pmol/L, in the low or conventionally considered low-normal range. Notably in this case there was no overt macrocytic anaemia, this is the blood change most commonly associated with B12 deficiency. The underlying cause of this case of B12 deficienct was gastric mucosal atrophy resulting from Helicobacter pylori infection. Following intramuscular B12 therapy and treatment of the underlying gastric infection, his symptoms improved.
A systematic review of approximately fifty case reports examining hallucinations in the context of B12 deficiency found consistent patterns: auditory and visual hallucinations, delusional thinking and mood disturbance, frequently occurring without the macrocytic anaemia clinicians are typically trained to look for. Many of these cases improved with B12 replacement and the review’s main finding was that psychiatric symptoms can precede the classic haematological signs of deficiency, meaning a normal blood count does not exclude a neurologically significant B12 problem.
Testing and interpreting B12 levels is can be tricky. Standard laboratory reference ranges are wide, often spanning roughly 200 to 950 (units vary by lab and country, commonly pg/mL, ng/L, or pmol/L and these are not directly interchangeable) and a result anywhere within that range is typically reported as normal. In practice, however, symptoms can appear from around 450, with levels ideally sitting at 700 or above for full neurological function.
Blood levels of B12 can also be misleading for a more practical reason: they may reflect recent dietary intake or supplementation, this can occur for many months after supplementation has stopped. Serum B12 can appear normal while a functional deficiency, meaning inadequate B12 activity at the cellular level, is already present and already affecting mood or cognition.
Methylmalonic acid (MMA) is a more reliable marker in this context, as it reflects what the body is actually taking up and using rather than what is circulating in the blood. As with any single marker, MMA still needs to be interpreted alongside symptoms and clinical presentation.
Certain clinical patterns should raise suspicion of B12 deficiency, these include new-onset depression accompanied by cognitive decline, psychosis or a history of psychosis, mood changes alongside neuropathic symptoms such as numbness, tingling, or gait changes, fatigue that feels disproportionate to the clinical picture, memory impairment, if following a vegetarian or vegan diet or if there is a history of acid-suppressing medication use or other gastric issues. Also check for possible autoimmune disease or a family history of pernicious anaemia. Borderline B12 levels should not automatically be treated as reassuring and the absence of anaemia does not rule out neurological vulnerability.
A client already taking a B12 supplement with persistently low or unchanged levels is not evidence that B12 isn’t the issue. Several factors can prevent supplementation from meaningfully raising status.
Oral B12 still depends on the same absorption pathway as dietary B12, meaning intrinsic factor and adequate stomach acid are still required for meaningful uptake. Where the underlying problem is impaired absorption rather than simply low dietary intake, an oral supplement may do very little regardless of the dose taken, because the bottleneck is the absorption mechanism itself, not the amount of B12 available to absorb.
The form of B12 used also matters. Cyanocobalamin, the most common and least expensive form found in many over-the-counter supplements, requires the body to convert it into an active form before use, an extra metabolic step that not everyone manages efficiently. Methylcobalamin and adenosylcobalamin are active forms that bypass this conversion step, and may be more effective for clients who are not responding to cyanocobalamin.
Dose and potency are also frequently underestimated. Many standard over-the-counter B12 supplements are formulated at doses too low to correct a significant deficiency, particularly where absorption is already compromised. In more severe or resistant cases, this is often why oral supplementation alone fails to move levels, and why intramuscular B12 injections, which bypass the digestive absorption pathway entirely, may be necessary to achieve a meaningful clinical response.
Where B12 deficiency is genuinely resistant to standard oral supplementation, an autoimmune cause should be considered. Pernicious anaemia is an autoimmune condition in which the body produces antibodies against intrinsic factor, the protein required to absorb B12 in the small intestine, or against the parietal cells of the stomach that produce both intrinsic factor and stomach acid. Without intrinsic factor, oral B12 cannot be absorbed effectively regardless of dose or form, which is why this condition typically requires B12 by injection rather than by mouth.
Autoimmune gastritis is closely related and can exist with or without progressing to full pernicious anaemia. It involves immune-mediated damage to the stomach lining, reducing both stomach acid and intrinsic factor production over time. Because this condition impairs stomach acid production directly, it can also affect the absorption of iron and other nutrients that depend on an acidic gastric environment, not B12 alone.
Where B12 deficiency is confirmed and does not respond to appropriate oral supplementation, testing for intrinsic factor antibodies and parietal cell antibodies is a reasonable next step to rule out an autoimmune cause, since the treatment approach differs significantly from a straightforward dietary or absorption-related deficiency.
Coeliac disease is another autoimmune condition worth considering in cases of resistant B12 deficiency. Damage to the small intestinal lining caused by gluten exposure can impair absorption of B12 and a range of other nutrients, and B12 deficiency is a recognised feature of untreated coeliac disease. Where deficiency persists despite treatment, or appears alongside other signs of malabsorption, coeliac screening is a reasonable part of the wider investigation.
In my own clinical work, B12 status is assessed alongside a full digestive history, particularly stomach acid function, rather than as an isolated blood marker. Where functional deficiency is suspected despite a “normal” serum result, methylmalonic acid testing, alongside a detailed symptom and dietary history, gives a much clearer picture than serum B12 alone. This is especially relevant for clients on restrictive diets, those with a history of gastric issues, and vegetarian or vegan clients, where the underlying digestive cause is often overlooked.
Vitamin B12 deficiency deserves far more attention in mental health assessment than it typically receives. The case literature is clear that psychiatric symptoms can appear before, and sometimes without, the classic blood changes clinicians are trained to look for. Where new-onset mood, cognitive, or psychotic symptoms appear without an obvious cause, B12 status deserves proper investigation.
If this is relevant to your own symptoms or someone you’re concerned about, book a consultation for a thorough assessment of B12 and broader nutrient status.
